In total, we investigated the levels of SOX10 in 195 patients, 85 with vitiligo and 110 with MM, and compared the levels to those of 85 healthy controls, demonstrating the added value of SOX10 measurement in MM. The gene discussed is SOX10; the disease is Miyoshi myopathy.